EA200600487A1 - Соединения инданилпиперазина, способ их получения и содержащие их фармацевтические композиции - Google Patents
Соединения инданилпиперазина, способ их получения и содержащие их фармацевтические композицииInfo
- Publication number
- EA200600487A1 EA200600487A1 EA200600487A EA200600487A EA200600487A1 EA 200600487 A1 EA200600487 A1 EA 200600487A1 EA 200600487 A EA200600487 A EA 200600487A EA 200600487 A EA200600487 A EA 200600487A EA 200600487 A1 EA200600487 A1 EA 200600487A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- optionally substituted
- benzene
- ring
- halogen
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Abstract
Соединение формулы (I)в которой Rпредставляет собой атом водорода и Rи Rвместе с атомами углерода, которые их несут, образуют кольцевую структуру бензола, нафталина или хинолина, предпочтительно бензольное кольцо, при этом каждая из этих кольцевых структур является необязательно замещенной одним или более идентичными или различными заместителями, выбранными из водорода, галогена и линейного или разветвленного C-Салкила, необязательно замещенного одним или более атомами галогена, или Rпредставляет собой атом водорода, a Rи Rвместе с атомами углерода, которые их несут, образуют кольцевую структуру бензола, нафталина или хинолина, предпочтительно бензольное кольцо, при этом каждая из этих кольцевых структур является необязательно замещенной одним или более идентичными или различными заместителями, выбранными из водорода, галогена и линейного или разветвленного C-Салкила, необязательно замещенного одним или более атомами галогена, n равно 1 или 2, -Х- представляет собой группу, выбранную из -(CH)-O-Ak-, -(CH)-NR-Ak-, -(CO)-NR-Ak- и -(CH)-NR-(CO)-, m представляет собой целое число от 1 до 6 включительно, Ak представляет собой необязательно замещенную цепь алкилена, a Rпредставляет собой атом водорода или группу алкила, Ar представляет собой группу арила или гетероарила, его оптические изомеры, а также соли присоединения фармацевтически приемлемой кислоты. Лекарственные средства.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0503071A FR2883876B1 (fr) | 2005-03-30 | 2005-03-30 | Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200600487A1 true EA200600487A1 (ru) | 2006-10-27 |
EA010051B1 EA010051B1 (ru) | 2008-06-30 |
Family
ID=35079249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200600487A EA010051B1 (ru) | 2005-03-30 | 2006-03-29 | Соединения инданилпиперазина, способ их получения и содержащие их фармацевтические композиции |
Country Status (37)
Country | Link |
---|---|
US (1) | US7442692B2 (ru) |
EP (1) | EP1707564B1 (ru) |
JP (1) | JP4503549B2 (ru) |
KR (1) | KR100766664B1 (ru) |
CN (1) | CN100467458C (ru) |
AP (1) | AP2007004169A0 (ru) |
AR (1) | AR054747A1 (ru) |
AT (1) | ATE372992T1 (ru) |
AU (1) | AU2006201326A1 (ru) |
BR (1) | BRPI0602132A (ru) |
CA (1) | CA2541066C (ru) |
CR (1) | CR9391A (ru) |
CY (1) | CY1107028T1 (ru) |
DE (1) | DE602006000102T2 (ru) |
DK (1) | DK1707564T3 (ru) |
EA (1) | EA010051B1 (ru) |
ES (1) | ES2293630T3 (ru) |
FR (1) | FR2883876B1 (ru) |
GE (1) | GEP20084544B (ru) |
GT (1) | GT200700084A (ru) |
HK (1) | HK1096386A1 (ru) |
HR (1) | HRP20070498T3 (ru) |
IL (1) | IL186062A (ru) |
MA (1) | MA28211A1 (ru) |
MX (1) | MXPA06003552A (ru) |
MY (1) | MY140325A (ru) |
NO (1) | NO20061334L (ru) |
NZ (1) | NZ546186A (ru) |
PL (1) | PL1707564T3 (ru) |
PT (1) | PT1707564E (ru) |
RS (1) | RS50527B (ru) |
SG (1) | SG126113A1 (ru) |
SI (1) | SI1707564T1 (ru) |
TN (1) | TNSN07357A1 (ru) |
UA (1) | UA87989C2 (ru) |
WO (1) | WO2006103342A2 (ru) |
ZA (1) | ZA200602631B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071778B2 (en) * | 2006-07-27 | 2011-12-06 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in CNS disorders |
US20090018163A1 (en) * | 2007-07-11 | 2009-01-15 | Bristol-Myers Squibb Company | Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
US8026257B2 (en) * | 2007-07-11 | 2011-09-27 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in CNS disorders |
US7632861B2 (en) * | 2007-11-13 | 2009-12-15 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in CNS disorders |
EP3628672A1 (en) | 2018-09-25 | 2020-04-01 | Antabio SAS | Indane derivatives for use in the treatment of bacterial infection |
WO2020064175A1 (en) | 2018-09-25 | 2020-04-02 | Antabio Sas | Indane derivatives for use in the treatment of bacterial infection |
EP3628666A1 (en) | 2018-09-25 | 2020-04-01 | Antabio SAS | Indane derivatives for use in the treatment of bacterial infection |
KR20210087448A (ko) | 2018-09-25 | 2021-07-12 | 앤타바이오 에스에이에스 | 박테리아 감염의 예방 또는 치료에 사용되는 인단 유도체 |
US20240016941A1 (en) | 2020-03-24 | 2024-01-18 | Antabio Sas | Combination therapy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1335591C (en) * | 1988-05-23 | 1995-05-16 | James Arthur Nixon | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
DK286990D0 (da) * | 1990-12-04 | 1990-12-04 | Lundbeck & Co As H | Indanderivater |
CA2175395A1 (en) * | 1995-06-02 | 1996-12-03 | Ronald J. Mattson | Melatonergic indanyl piperazines or homopiperazines |
FR2769312B1 (fr) * | 1997-10-03 | 1999-12-03 | Adir | Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2827284B1 (fr) * | 2001-07-16 | 2003-10-31 | Servier Lab | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP1558253A4 (en) * | 2002-10-30 | 2007-07-25 | Merck & Co Inc | PIPERIDINYL ALPHA AMINOAMIDE MODULATORS DERCHEMOKIN RECEPTOR ACTIVITY |
-
2005
- 2005-03-30 FR FR0503071A patent/FR2883876B1/fr not_active Expired - Fee Related
-
2006
- 2006-03-16 MA MA28880A patent/MA28211A1/fr unknown
- 2006-03-23 NO NO20061334A patent/NO20061334L/no not_active Application Discontinuation
- 2006-03-28 NZ NZ546186A patent/NZ546186A/en not_active IP Right Cessation
- 2006-03-28 GE GEAP20069324A patent/GEP20084544B/en unknown
- 2006-03-28 SG SG200602026A patent/SG126113A1/en unknown
- 2006-03-29 AP AP2007004169A patent/AP2007004169A0/xx unknown
- 2006-03-29 EA EA200600487A patent/EA010051B1/ru not_active IP Right Cessation
- 2006-03-29 PT PT06290494T patent/PT1707564E/pt unknown
- 2006-03-29 US US11/391,916 patent/US7442692B2/en not_active Expired - Fee Related
- 2006-03-29 SI SI200630005T patent/SI1707564T1/sl unknown
- 2006-03-29 ES ES06290494T patent/ES2293630T3/es active Active
- 2006-03-29 PL PL06290494T patent/PL1707564T3/pl unknown
- 2006-03-29 WO PCT/FR2006/000673 patent/WO2006103342A2/fr not_active Application Discontinuation
- 2006-03-29 DK DK06290494T patent/DK1707564T3/da active
- 2006-03-29 MY MYPI20061369A patent/MY140325A/en unknown
- 2006-03-29 RS RSP-2007/0478A patent/RS50527B/sr unknown
- 2006-03-29 DE DE602006000102T patent/DE602006000102T2/de active Active
- 2006-03-29 EP EP06290494A patent/EP1707564B1/fr active Active
- 2006-03-29 UA UAA200603429A patent/UA87989C2/ru unknown
- 2006-03-29 AT AT06290494T patent/ATE372992T1/de active
- 2006-03-30 AU AU2006201326A patent/AU2006201326A1/en not_active Abandoned
- 2006-03-30 AR ARP060101238A patent/AR054747A1/es not_active Application Discontinuation
- 2006-03-30 ZA ZA200602631A patent/ZA200602631B/xx unknown
- 2006-03-30 MX MXPA06003552A patent/MXPA06003552A/es active IP Right Grant
- 2006-03-30 CA CA2541066A patent/CA2541066C/fr not_active Expired - Fee Related
- 2006-03-30 JP JP2006093025A patent/JP4503549B2/ja not_active Expired - Fee Related
- 2006-03-30 KR KR1020060029085A patent/KR100766664B1/ko not_active IP Right Cessation
- 2006-03-30 BR BRPI0602132-8A patent/BRPI0602132A/pt not_active IP Right Cessation
- 2006-03-30 CN CNB2006100669637A patent/CN100467458C/zh not_active Expired - Fee Related
-
2007
- 2007-02-01 HK HK07101184.7A patent/HK1096386A1/xx not_active IP Right Cessation
- 2007-09-18 TN TNP2007000357A patent/TNSN07357A1/en unknown
- 2007-09-19 IL IL186062A patent/IL186062A/en not_active IP Right Cessation
- 2007-09-24 CR CR9391A patent/CR9391A/es not_active Application Discontinuation
- 2007-09-28 GT GT200700084A patent/GT200700084A/es unknown
- 2007-10-25 HR HR20070498T patent/HRP20070498T3/xx unknown
- 2007-11-28 CY CY20071101540T patent/CY1107028T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200600487A1 (ru) | Соединения инданилпиперазина, способ их получения и содержащие их фармацевтические композиции | |
ES2525763T3 (es) | Derivados del ácido fenilalcanoico sustituido y sus usos para el tratamiento de enfermedades respiratorias | |
EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
AR049401A1 (es) | Aza-biciclononanos | |
ATE556058T1 (de) | 1-(2h)-isochinolonderivat | |
BR0315405A (pt) | Compostos inibidores da integrase tricìclica pré-organizados | |
EA201070202A1 (ru) | Производное оксопиразина и гербицид | |
EA200000792A3 (ru) | Новые пиридиновые соединения, способ их получения и содержащие их фармацевтические композиции | |
EA201001087A1 (ru) | Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
EA200600551A1 (ru) | Соединения пиперазина, способ их получения и фармацевтические композиции, которые их содержат | |
EA200401077A1 (ru) | 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b | |
FR2795072B1 (fr) | Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
EA200101204A1 (ru) | Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции | |
EA200400756A1 (ru) | Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат | |
EA200900480A1 (ru) | Новые соединения индола, способ их получения и фармацевтические композиции, которые их содержат | |
EA200001248A1 (ru) | Новые линейные и циклические производные мочевины, способ их получения и их содержащие фармацевтические композиции | |
EA200500716A1 (ru) | Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат | |
RU2014101999A (ru) | Производные пиперазина, способы их получения и их применение в лечении инсулинорезистентности | |
EA201000867A1 (ru) | Новые соединения 2-меркаптоциклопентанкарбоновой кислоты, способ их получения и содержащие их фармацевтические композиции | |
PT1572198E (pt) | Novos compostos farmaceuticos com actividade de receptor alfa2. | |
CU20070216A7 (es) | Derivados de indanil-piperazinas, su procedimiento de preparación y las composiciones farmacéuticas que lo contienen | |
NO20022891L (no) | Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem | |
TH22954A (th) | อนุพันธ์เฮเทอโรไซคลิค สไปโร | |
TH85134A (th) | อนุพันธ์ไอโซอินโดลีนต่าง ๆ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |